Source comparison
AOD-9604 vs HGH Fragment 177-191: Key Differences in Research Settings
Research Notice: This article covers research on AOD-9604 research peptide and Tesamorelin research peptide — available from Palmetto Peptides for laboratory use only. Research Use Only Disclaimer: All peptides listed on this page are sold exclusively for in v
This comparison does not assign a generated winner or score.
- Research Notice: This article covers research on AOD-9604 research peptide and Tesamorelin research peptide — available from Palmetto Peptides for laboratory use only.
- Research Use Only Disclaimer: All peptides listed on this page are sold exclusively for in vitro and legitimate laboratory research purposes. They are not intended for human consumption, veterinary use, or any clinical application. The information in this article is for scientific and educational reference only and does not constitute medical advice. All research use must comply with applicable federal, state, and institutional regulations. Palmetto Peptides complies fully with all applicable FDA guidelines.
- Research Disclaimer: AOD-9604 and HGH fragment 177-191 are research compounds not approved by the FDA for human or veterinary use. This comparison is provided for scientific and educational purposes only and does not constitute medical advice.
- For researchers navigating the literature on growth hormone-derived peptide fragments, one of the most common points of confusion is the relationship between AOD-9604 and the native HGH fragment 177-191. They share a core sequence, they are derived from the same region of human growth hormone, and they are often discussed in overlapping contexts. However, they are structurally distinct compounds that behave differently in certain research applications. This article breaks down those differences clearly.
- Last Updated: April 6, 2026 | Reading Time: Approximately 8 minutes | Author: Palmetto Peptides Research Team